Physician profile
Ravi Sharma
NPI 1205817814
$1,012.24
in general payments reported to CMS, 2019-2025
11 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.15 · 2020: $32.94 · 2021: $87.00 · 2022: $151 · 2023: $283 · 2024: $85.66 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $457.82 | 2021-2025 | Venclose Maven Catheter, Fluency Endovascular Stent Graft, Atlas |
| Abbott Laboratories | $148.22 | 2023 | Dragonfly Opstar |
| Boston Scientific Corporation | $131.11 | 2020-2024 | Varithena Administration Pack |
| Medtronic, INC. | $71.65 | 2022-2023 | Venaseal |
| Agiliti Surgical, INC. | $53.68 | 2019 | |
| Medtronic Vascular, INC. | $46.02 | 2019-2020 | |
| Cashflow Solutions, LLC | $25.31 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Organogenesis INC. | $23.19 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $22.86 | 2023 | |
| Angiodynamics, INC. | $17.76 | 2022 | |
| Bsn Medical INC | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.